Objective: To examine age-related differences in blood pressure, heart rate, behavioral mood state and norepinephrine kinetics after caffeine ingestion in younger and older men. Design: Placebo-controlled, double-blind study. Setting: General Clinical Research Center, University of Vermont. Subjects: 10 older (O) (65 ± 80 y) and 10 younger (Y) (19 ± 26 y) healthy men who were moderate consumers of caffeine (Y 126 AE 30 mgad; O 160 AE 44 mgad:NS; mean AE s.e.m.). Intervention: All volunteers were characterized for fasting plasma glucose, insulin and caffeine levels, body composition, anthropometry, physical activity, and energy intake. Before and after placebo and caffeine ingestion (5 mgakg fat-free mass) test days, the following variables were measured in all subjects: heart rate, blood pressure, mood state, and norepinephrine concentrations (NEconc), appearance (NEapp) and clearance (NEcl). Main outcome measures: Systolic and diastolic blood pressure, heart rate, mood state, and norepinephrine kinetic responses to placebo and caffeine ingestion. Results: Following caffeine ingestion, plasma caffeine levels were similar in Y and O men. Systolic (SBP) and diastolic (DBP) blood pressure increased signi®cantly (P`0.01) from baseline by 9% (130 AE 6 vs 142 AE 6 mmHg) and 3% (75 AE 3 vs 77AE 3 mmHg), respectively, in O men following caffeine ingestion, but remained unchanged in Y men. Self-reported feelings of tension (P`0.05) and anger (P 0.06) decreased in O men, while anger tended to increase in Y men (P`0.06) following caffeine ingestion. Heart rates in both groups were unaltered following caffeine ingestion. No differences were noted at baseline between O and Y men for NEconc, NEapp and NEcl. After caffeine ingestion, NEconc were signi®cantly greater in O than Y men, whereas NEapp and NEcl rates did not differ from baseline in either group. Blood pressure and subjective mood state effects of caffeine were not related to changes in norepinephrine kinetics. Conclusion: Age may play a role in augmenting blood pressure response and reducing subjective feelings of anger and tension following caffeine ingestion, suggesting that the elderly are more reactive to the pressor and less sensitive to the subjective effects of the drug. These effects do not appear to be mediated by changes in sympathetic nervous system activity.
Introduction
There are age-related differences in physiological and psychological response to stressors in older compared to younger individuals. Speci®cally, the blood pressure response to environmental (Palmer et al, 1979) and pharmacological stressors (Izzo et al, 1983 ) is greater in older compared to younger individuals, which may contribute to cardiovascular risk in older individuals. In addition, older individuals report less change in subjective feelings of mood state following stimulation with commonly consumed drugs (e.g. caffeine) acting on the central nervous system (Swift & Tiplady, 1988) . Taken together, this uncoupling of subjective mood response from heightened cardiovascular reactivity to commonly encountered stimuli in older compared to younger individuals suggests an agerelated decrement in the regulation of blood pressure, as well as subjective mood state.
Caffeine is found in a variety of common foods and drinks, as well as many over-the-counter medicines and is widely consumed by the elderly (Blanchard & Sawers, 1983) . Caffeine ingestion increases blood pressure (Robertson et al, 1978; Pincomb et al, 1985; Benowitz, 1990; James, 1994) , but its effects on catecholamines are inconclusive (Bellet et al, 1969; Robertson et al, 1978; Jung et al, 1981; Poehlman et al, 1985 Poehlman et al, , 1989 Smits et al, 1985 Smits et al, , 1987 Benowitz et al, 1995) . Moreover, caffeine affects subjective feelings of well-being, most likely via its stimulatory effects on the central nervous system (Swift & Tiplady, 1988; Yu et al, 1991; Smith et al, 1992; Hassenfratz & Battig, 1994) . Speci®cally, caffeine improves feelings of alertness and attention and reduces fatigue (Swift & Tiplady, 1988; Yu et al, 1991) . However, little information is available regarding the effects of caffeine ingestion on blood pressure, heart rate, and behavioral mood state response and their relationship to changes in sympathetic nervous system activity in younger compared to older individuals. The primary purpose of this study was to assess changes in blood pressure, heart rate, and behavioral mood state response under caffeine and placebo conditions in younger and older men. Our second objective sought to determine whether changes in sympathetic nervous system activity (SNSa), as measured by norepinephrine kinetics, was associated with changes in these variables.
Methods

Subjects
Physical characteristics of the participants in the present study and their changes in energy expenditure, substrate oxidation, and norepinephrine kinetics in response to caffeine ingestion have been reported previously (Arciero et al, 1995) , and only a necessary minimum will be repeated in the present paper. All experiments were carried out in one series, with the original study design aiming to examine the effects of caffeine on energy expenditure, substrate oxidation, norepinephrine kinetics, blood pressure and mood state. Ten younger (19 ± 26 years) and 10 older (65 ± 80 years) healthy male volunteers who regularly consumed moderate amounts of caffeinated substances (self-reported mean intake: Y 126 AE 30; O 160 AE 44 mgaday; P 0.60) were recruited. Because heavy caffeine intake induces tolerance to some of the metabolic and cardiovascular effects of caffeine (Robertson et al, 1981) , excessive caffeine-consumers ( b 4 cups of coffee per day) were not included in the study.
Subjects were excluded from participation in the study due to: (a) history of cardiovascular disease; (b) abnormal resting or exercise 12-lead electrocardiogram (EKG) (e.g., ST-segment depression greater than 1 mm at rest or 2 mm during exercise, inverted T waves, etc.); (c) hypertension (supine blood pressure b 160a90 mmHg); (d) history of diabetes mellitus; (e) history of renal failure; (f) history of liver disease; (g) use of tobacco products within the previous 3 months; (h) weight instability (AE 2 kilograms) within the past year as assessed by health history questionnaire; (i) body weight that is 15% above or below ideal based on their age group according to the 1983 Metropolitan Life Insurance weight tables (Abraham, 1983) ; and (j) exercise-limiting noncardiac disease (arthritis, peripheral vascular disease, cerebral vascular disease, etc.). None of the subjects was currently taking medications or engaged in a regular exercise program. The nature, purpose, and possible risks were carefully explained to all subjects before they gave their written consent to participate in the study. The experimental protocol was approved by the committee on Human Research for the Medical Sciences of the University of Vermont.
Experimental design and procedures
This experiment was a placebo-controlled, double-blind test of ingestion of caffeine (5 mgakg fat-free mass FFM)) and placebo (lactose) conducted in two separate treatment blocks sequenced in a randomized order and performed within a 1-month period. Each subject participated in both blocks, consisting of placebo and caffeine ingestion administered in pill form.
Order of testing: Prior to the ®rst in-patient visit, all subjects had their fat-free mass (FFM) and fat mass (FM) determined by underwater weighing. Within one month following their initial out-patient visit, subjects were admitted the afternoon prior to their ®rst in-patient test between 14.00 and 16.00. Subjects were instructed to abstain from all caffeine-containing beverages for 48 h prior to test day to remove tolerance effects to caffeine (Benowitz, 1990) . For the second in-patient test, subjects underwent the same procedures but received the treatment not administered during the ®rst in-patient visit.
Testing procedures: At the ®rst in-patient visit, each subject had all testing procedures explained. Thereafter, subjects consumed their dinner (1000 kcal; 55% carbohydrate; 30% fat; 15% protein) at 18.00 and were asked to be in bed by 22.00. Starting at 06.00 the next morning, an intravenous line was placed in a forearm vein for tracer infusion of [ 3 H]norepinephrine. A second intravenous line was placed retrograde in a dorsal vein of the opposite hand, which was placed in a warming box (70 C) to arterialize the blood. This hand was used for blood sampling. The subject was instructed to lie quietly for 30 min before testing began. The following resting baseline measurements were collected by the principal investigator (P.J.A.) for the next 90 min and averaged, providing a mean value: norepinephrine kinetics (50 and 60 min); blood pressure and heart rate (0, 40, and 90 min); and Pro®le of Mood States Questionnaire (McNair et al, 1971 ) (90 min, pre-caffeine). Between 09.30 and 09.45, each subject was administered either placebo (lactose) or caffeine (5 mgakg FFM) in pill form with 50 ml of tepid water, followed by 90 min of continuous measurements of norepinephrine kinetics and measurements at 15-min intervals of blood pressure and heart rate. The Pro®le of Mood States questionnaire was administered again immediately following the 90 min (post-caffeine).
Body composition: Body density was measured and body fat was estimated from underwater weighing with simultaneous determination of lung volume by helium dilution. Body fat percentage was calculated according to the Siri equation (Siri, 1956) . Estimated daily energy intake: Energy intake, sodium and caffeine consumption were determined from a 3-day food diary. Brie¯y, each subject was asked to weigh and record all foods and beverages ingested for two weekdays and one weekend day. Particular emphasis was placed on the importance of maintaining typical eating habits and describing foods and method of preparation in accurate detail. The Nutritionist III computer program (N-Squared Computing, 4.0 version) was used to analyze all diets for energy, sodium and caffeine intake as well as relative and absolute quantities of macronutrients.
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Time course of plasma sampling, blood pressure, heart rate, and mood state Measurement of norepinephrine kinetics: The in-patient testing procedures are shown in Figure 1 . Norepinephrine kinetics (appearance and clearance rates) were performed under steady-state conditions using a modi®cation of the tritiated isotope-dilution method of Esleret al (1979) and as previously described (Poehlman et al, 1990) . [
3 H]Norepinephrine was infused continuously (Harvard Apparatus, S. Natick, MA, USA) for 180 min at a dose of 0.71 mCiamin. Before caffeine and placebo ingestion, arterialized blood samples were drawn at 50 and 60 min of the infusion for determination of baseline steady-state plasma norepinephrine concentrations and 3 H activity of plasma norepinephrine, and at 120, 150, and 180 min for determination of steady-state caffeine and placebo kinetics. Calculation of norepinephrine plasma clearance, appearance, and concentrations have been reported previously (Arciero et al, 1995) . The intraclass correlation for repeat determinations of norepinephrine concentrations, appearance, and clearance were 0.79, 0.77, and 0.91 for younger and 0.84, 0.90, and 0.95 for older men, respectively.
Blood pressure and heart rate: An automated machine (Dinamap, Critikon, Tampa, FL, USA) was used to obtain resting baseline supine heart rate and blood pressure measurements from the right brachial artery at 0, 40, and 90 min and at 105, 120, 135, 150, 165, and 180 min for determination of placebo and caffeine-stimulated conditions. Measurements were obtained following a 12-hour overnight fast in the Clinical Research Center.
Behavioral mood state: The Pro®le of Mood States (POMS) questionnaire (McNair et al, 1971) , a standardized test sensitive to caffeine ingestion (Chait & Grif®ths, 1983) , was administered by the principal investigator (P.J.A.) to each subject at four different times during the testing conditions: (a) prior to caffeine; (b) post-caffeine; (c) prior to placebo; and (d) post-placebo. The POMS consists of 65 adjectives that are each rated on a 5-point scale and when analyzed yields six factors: tension-anxiety, depression-dejection, anger-hostility, vigor-activity, fatigueinertia, and confusion-bewilderment.
Plasma caffeine analysis
Plasma caffeine levels were assayed by gas chromatography, as reported previously by Shi et al (1993) .
Statistical analysis
The effects of caffeine versus placebo were assessed by comparing the values of mood state obtained during the two tests using Student's paired t-tests. A 264 repeated-measures analysis of variance was used to test for the effects of age group and the time course of concentrations of norepinephrine, [ 3 H]norepinephrine and plasma caffeine during the two test days. The effects of caffeine in the younger and older men were compared using an analysis of variance. Since younger and older men differed in baseline blood pressure and heart rate values, an analysis of covariance (ANCOVA), with the initial baseline values serving as the covariates, was used to test for the effects of caffeine ingestion on blood pressure and heart rate. A Pearson Product Moment Correlation Coef®cient was used to estimate associations between variables. All data are expressed as mean AE s.e.m., unless noted otherwise. Tukey posthoc comparisons were performed to locate mean differences when an interaction was found (Glass & Hopkins, 1984) . Statistical signi®cance was set at P`0.05.
Results
Physical characteristics
The physical characteristics of the younger and older men are shown in Table 1 . Older men had a greater (P`0.05) absolute quantity of body fat and less (P`0.05) fat-free mass than the younger men. There was no difference between younger and older men for fasting plasma level or self-reported intake of caffeine and sodium. Selfreported energy intake was $ 832 kcals greater in younger than older men (P`0.05). Table 2 ).
Blood pressure and heart rate Figures 2 and 3 show systolic and diastolic blood pressures, respectively, at rest and in response to caffeine and placebo in the Y and O men. Resting systolic blood pressure (Y 119 AE 3 placebo vs 118.9 AE 3 caffeine; O 130 AE 5.4 placebo vs 129.8 AE 5.8 caffeine, mmHg) and diastolic blood pressure (Y 61 AE 2 placebo vs 61.2 AE 2 caffeine; O 75.5 AE 3 placebo vs 74.6 AE 3 caffeine, mmHg) were similar (P 0.66 to 0.98) between the caffeine and placebo conditions within each group. Therefore, values were averaged to yield a single baseline measurement for both systolic and diastolic pressure in each group. Resting baseline systolic (SBP) and diastolic (DBP) blood pressures were signi®cantly lower in Y than O men (P`0.01). Following caffeine ingestion, SBP (9%) and DBP (3%) increased signi®cantly (P`0.01) from baseline in the O men, whereas SBP and DBP remained statistically unchanged (P 0.87) from baseline in Y men.
Resting heart rate values were not different between placebo and caffeine treatments within each group and were averaged to obtain a single measurement. Resting baseline heart rate was lower (P`0.05) in younger (56 AE 8 bpm) than older (62 AE 6 bpm) men. Heart rates in both groups were unaltered following caffeine ingestion Signi®cantly different from older men: * P`0.01, ** P`0.05. Caffeine effects in younger and older men PJ Arciero et al (data not shown in table form). No signi®cant interactions were noted for blood pressure or heart rate in the two groups.
Behavioral mood state
The results from the Pro®le of Mood States questionnaire (POMS) showed no differences among the pre-placebo, pre-caffeine, and post-placebo conditions in both groups; thus only the data from the caffeine test day is presented (Table 3 ). There were no differences in POMS scores between the groups prior to caffeine ingestion. However, self-reported feelings of tension decreased (P`0.05) in older men, whereas anger tended to decrease (P 0.06) in older and increase (P 0.06) in younger men following caffeine ingestion. All other mood states were not signi®-cantly different between the groups and no signi®cant interactions were noted. Table 4 shows the norepinephrine kinetic data in the younger and older men before and after caffeine ingestion and as reported previously (Arciero et al, 1995) . Because baseline and placebo test-day values of norepinephrine concentration, appearance, and clearance rates were not signi®cantly different, a mean baseline value was used. The only signi®cant difference between the two groups was a 26% higher norepinephrine concentration following caffeine ingestion in older compared with younger men. Table 5 shows the Pearson product-moment correlation coef®cients among the SNSa, mood state, and blood pressure variables assessed in the present study. The only correlate to NE kinetics was the relative changes in NEcl with DBP in the younger men following caffeine ingestion (r 0.71; P`0.05).
Norepinephrine kinetics
Relation of SNSa, BP, and behavioral mood state
Discussion
The major ®ndings of this study are: (1) caffeine ingestion increases plasma levels of caffeine similarly in younger and older men; (2) SBP and DBP remain elevated throughout the measurement period in older men, whereas, in younger men SBP and DBP remain statistically unchanged from baseline levels following caffeine ingestion; (3) selfreported feelings of tension and anger are attenuated in older men, whereas feelings of anger are augmented in younger men following caffeine ingestion; and (4) changes in SNSa do not appear to be related to changes in blood pressure and mood state following caffeine ingestion in younger or older men.
Blood pressure and caffeine
This study showed that systolic (SBP) and diastolic (DBP) blood pressure increased signi®cantly following caffeine ingestion and persisted until the termination of the study only in older men. Our ®nding of increased SBP and DBP response in healthy normotensive older men following caffeine ingestion has been corroborated by others (Conrad et al, 1982; Lenders et al, 1988; Haig et al, 1993) . It is important to note that our older subjects were normotensive, as most previous research supports an elevated pressor response to caffeine in hypertensive patients (Smits et al, 1986; Sung et al, 1994; Pincomb et al, 1996) , although this ®nding is not universal . At present, only one other study has directly compared the in¯uence of caffeine ingestion on the blood pressure response between younger and older men (Izzo et al, 1983) . Izzo et al (1983) studied 10 caffeine users and 10 nonusers, of which 12 were younger (`30 years) and 8 were older ( b 50 years). They observed a signi®cantly greater blood pressure response in the older men. However, the present study is the ®rst to systematically examine the in¯uence of caffeine ingestion in older and younger men using a placebo-controlled, double-blind design that permits the subjects to serve as their own control, thus allowing for an unbiased assessment of the treatments.
The majority of studies that have examined the in¯uence of caffeine ingestion on blood pressure response have reported an increase in blood pressure in caffeine-naive individuals, but no change in habitual users (Robertson et al, 1978 (Robertson et al, , 1981 ; Sharp & Benowitz, 1990) , suggesting that tolerance occurs in response to the cardiovascular effects of caffeine in habitual consumers (Robertson et al, 1981) . In Signi®cantly different from baseline and younger men: * P`0.05; **P 0.06.
Caffeine effects in younger and older men PJ Arciero et al the present study, all subjects underwent a 2-day abstinence of all caffeine-containing foods and beverages, as this length of time is suf®cient to account for individual differences in plasma caffeine elimination half-life and remove the possibility of prior tolerance (Benowitz, 1990; Smits et al, 1985) . Tolerance was not evident in our subjects at the time of caffeine dosing based on the considerable increase in systolic and diastolic blood pressure observed in the older men and diastolic blood pressure in younger men. The mechanism(s) of the pressor effect following caffeine ingestion cannot be elucidated in this study. The pressor effect of caffeine has been attributed to local antagonism of adenosine-mediated vasodilation (Smits et al, 1987) and increased sympathetic nervous system activity (Robertson et al, 1978) . The ®ndings from our previous study (Arciero et al, 1995) , as well as others (Izzo et al, 1983; Poehlman et al, 1989; Conrad, et al, 1982) , do not support a role for undifferentiated sympathetic nervous system stimulation due to little or no increase in plasma norepinephrine following caffeine administration, and the ®nding of no difference in baseline or caffeine-stimulated norepinephrine kinetics in either of the two groups (Arciero et al, 1995) . Epinephrine release from the adrenal medulla may have contributed to the increased SBP, but not DBP, response to caffeine observed in our older subjects (Conrad et al, 1982) . However, because epinephrine was not measured in the present study, this mechanism cannot be ruled out as an important mediator of the observed pressor response. It is possible that our ®nding of no change in SBP and DBP in the younger men may have been partially due to the dose of caffeine being below the threshold necessary to stimulate a pressor effect either via the sympathetic nervous system or by some other yet unde®ned mechanism. However, this is unlikely given that energy expenditure and fatty acid availability rose signi®-cantly following the same dose (5 mgakg FFM), as shown in our previous study (Arciero et al, 1995) . Moreover, others have shown that as little as 2 mgakg elicits signi®-cant SNSa and blood pressure effects . Thus, it appears that younger men are protected from the pressor effect of the same relative amounts of caffeine compared with older men. This issue deserves further study.
Caffeine and behavioral mood state Previous investigations have reported discrepant results regarding the behavioral and psychological effects of caffeine, with some showing increased feelings of wellbeing (Swift & Tiplady, 1988; Yu et al, 1991; Smith et al, 1992) and others showing either no effects (Swift & Tiplady, 1988; Lieberman et al, 1987) or decreased feelings of well-being (France & Ditto, 1992) . Plausible reasons for the discrepant behavioral mood state responses following caffeine ingestion are not clear but may be in¯uenced by baseline caffeine levels (Goldstein et al, 1965) , age and sex of the subjects, and dose of caffeine administered. In the present study, all subjects followed a similar caffeine abstinence practice (48 h) prior to each testing session, which was veri®ed by similar baseline plasma caffeine levels in both groups, and the dose of caffeine was administered on the same relative basis (5 mgakg FFM) in all 20 male volunteers. This is the ®rst study to compare directly the effects of caffeine ingestion on behavioral mood state in younger versus older men using a double-blind, placebo-controlled design. Our ®ndings revealed an attenuation in subjective feelings of anger and tension in older men following caffeine ingestion and increased feelings of anger in younger men after caffeine ingestion. Although the precise mechanism responsible for the undesirable behavioral mood response (anger) of caffeine in the younger men is beyond the scope of this study, it may involve adenosine receptor inhibition in the CNS that is associated with increased feelings of restlessness, tremor, and insomnia (Rall, 1985; Spealman, 1988) .
To our knowledge, only one other study has compared the effects of caffeine ingestion on mood state response in younger and older individuals (Swift & Tiplady, 1988) . These investigators showed improved feelings of wellbeing in younger subjects with no change observed in the elderly. The most likely reasons for the discrepant ®ndings between the present study and those of Swift and Tiplady (1988) are: (1) the smaller number of subjects in their study (n 6 younger, 6 older); (2) differences in caffeine administration dose in their study (200 mg was administered to both young and old); (3) subjective measures were limited to visual analogue scales consisting of only four feelings; and (4) the use of both males (N 5) and females (N 7) Caffeine effects in younger and older men PJ Arciero et al combined in the Swift & Tiplady (1988) study. Thus, the validity of our ®ndings are strengthened by our study design and comprehensive nature of our testing procedures.
Relation of SNSa, blood pressure and behavioral mood state The present study is the ®rst to assess simultaneously changes in SNSa with blood pressure and mood state changes following caffeine ingestion in younger and older men. Although there were minor changes in SNSa following caffeine (increased NEconc), they were not associated with the signi®cant changes in blood pressure and mood state in the two groups. This ®nding was contrary to our initial hypothesis of caffeine increasing blood pressure and mood state through heightened SNSa. It is important to note that SBP increased early (0 ± 30 min) in older men (Figure 2 ), but, because no measures of SNSa were obtained during this period, a relationship between these variables cannot be discussed. The most plausible explanation for this phenomenon is that the predominant action of caffeine occurs at the adrenomedullary level rather than merely through undifferentiated sympathetic stimulation (Robertson et al, 1978) and thus in¯uences epinephrine levels (not measured in the present study) substantially more than norepinephrine levels. Future studies should address this issue.
It is important to note several methodological aspects of the present study that reinforce the validity of our ®ndings. First, this study afforded strict control for individual differences among subjects by employing a repeated measures design, using a placebo and caffeine condition that was administered in a double-blind fashion. Second, all measurement techniques were highly standardized to ensure optimal basal conditions. These experimental procedures included: (a) the measurement of blood pressure, heart rate, behavioral mood state and norepinephrine kinetics in an inpatient setting under identical testing conditions; (b) measurements were performed $ 48 h after the last ingestion of caffeine-containing food items to avoid the residual effects of caffeine on our dependent variables; (c) the habituation of volunteers to all test conditions the evening prior to testing; and (d) the design of the study (subjects served as their own control).
In conclusion, our ®ndings suggest that age plays a role in augmenting blood pressure response and attenuates subjective feelings of anger and tension following caffeine ingestion in habitual consumers of caffeine, implying that older individuals are more susceptible to the pressor and less sensitive to the subjective effects of the drug. These changes do not appear to be mediated by SNSa.
